Wild‐type KRAS were detected for all patients, and the higher copy numbers of total KRAS transcripts were used to differentiate pancreatic cancer from healthy donor and monitor the disease progression of pancreatic cancer. This evidence concerns the gene KRAS and pancreatic neoplasm.